{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:52:51Z","timestamp":1765486371217,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","award":["19K17535"],"award-info":[{"award-number":["19K17535"]}],"id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.carrev.2019.10.012","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T20:50:50Z","timestamp":1571777450000},"page":"127-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Second-Generation Drug-Eluting Resorbable Magnesium Scaffold: Review of the Clinical Evidence"],"prefix":"10.1016","volume":"21","author":[{"given":"Yuichi","family":"Ozaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector M.","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Shlofmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Hideo-Kajita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2019.10.012_bb0005","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/eht542","article-title":"Bioresorbable scaffolds: rationale, current status, challenges, and future","volume":"35","author":"Iqbal","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2019.10.012_bb0010","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.jacc.2014.09.041","article-title":"Current status of bioresorbable scaffolds in the treatment of coronary artery disease","volume":"64","author":"Wiebe","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.10.012_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)00447-X","article-title":"Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial","volume":"387","author":"Haude","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2019.10.012_bb0020","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/eurheartj\/ehw196","article-title":"Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial","volume":"37","author":"Haude","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2019.10.012_bb0025","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4244\/EIJ-D-17-00254","article-title":"Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III","volume":"13","author":"Haude","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2019.10.012_bb0030","first-page":"E502","article-title":"Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III","volume":"92","author":"Haude","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.012_bb0035","doi-asserted-by":"crossref","unstructured":"Haude M, Ince H, T\u00f6lg R, Lemos PA, von Birgelen C, Christiansen EH, et al. Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: 3-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial. EuroIntervention 2019 Feb 26 [E-pub ahead of print], doi: https:\/\/doi.org\/10.4244\/EIJ-D-18-01000.","DOI":"10.4244\/EIJ-D-18-01000"},{"key":"10.1016\/j.carrev.2019.10.012_bb0040","doi-asserted-by":"crossref","unstructured":"Verheye S, Wlodarczak A, Montorsi P, Bennett J, Torzewski J, Haude M, et al. Safety and performance of a resorbable magnesium scaffold under real-world conditions: 12-month outcomes of the first 400 patients enrolled in the BIOSOLVE-IV registry. EuroIntervention 2019 Jan 22 [E-pub ahead of print], doi: https:\/\/doi.org\/10.4244\/EIJ-D-18-01058.","DOI":"10.4244\/EIJ-D-18-01058"},{"key":"10.1016\/j.carrev.2019.10.012_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004762","article-title":"Comparison of acute thrombogenicity for metallic and polymeric bioabsorbable scaffolds: magmaris versus Absorb in a porcine arteriovenous shunt model","volume":"10","author":"Waksman","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.012_bb0050","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.4244\/EIJ-D-17-00958","article-title":"Comparison of acute thrombogenicity for magnesium versus stainless steel stents in a porcine arteriovenous shunt model","volume":"14","author":"Lipinski","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2019.10.012_bb0055","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4244\/EIJ-D-16-00915","article-title":"Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model","volume":"13","author":"Waksman","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2019.10.012_bb0060","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/ehjci\/jey210","article-title":"Impact of procedural characteristics on coronary vessel wall healing following implantation of second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions: an optical coherence tomography analysis","volume":"20","author":"Ozaki","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2019.10.012_bb0065","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0140-6736(07)60853-8","article-title":"Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial","volume":"369","author":"Erbel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2019.10.012_bb0070","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.4244\/EIJ-D-15-00371","article-title":"Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial","volume":"12","author":"Haude","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2019.10.012_bb0075","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/eurheartj\/ehy223","article-title":"Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document","volume":"39","author":"Garcia-Garcia","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2019.10.012_bb0080","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(15)01039-9","article-title":"1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis","volume":"387","author":"Stone","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2019.10.012_bb0085","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1093\/eurheartj\/ehx155","article-title":"Late thrombotic events after bioresorbable scaffold implantation: a systematic review and meta-analysis of randomized clinical trials","volume":"38","author":"Collet","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2019.10.012_bb0090","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/CIRCULATIONAHA.117.031843","article-title":"Three-year outcomes with the Absorb bioresorbable scaffold: individual-patient-data meta-analysis from the ABSORB randomized trials","volume":"137","author":"Ali","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2019.10.012_bb0095","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(09)60325-1","article-title":"A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods","volume":"373","author":"Serruys","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2019.10.012_bb0100","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4244\/EIJV9I11A217","article-title":"Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months","volume":"9","author":"Serruys","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2019.10.012_bb0105","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.jcin.2018.02.040","article-title":"Restenosis in Magmaris stents due to significant collapse","volume":"11","author":"Yang","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.012_bb0110","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005677","article-title":"Restenosis in a collapsed Magmaris bioresorbable scaffold","volume":"10","author":"Barkholt TO","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.012_bb0115","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.recesp.2017.11.010","article-title":"Optical coherence tomography of magnesium bioresorbable scaffold restenosis","volume":"71","author":"Garc\u00eda-Blas","year":"2018","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda"},{"key":"10.1016\/j.carrev.2019.10.012_bb0120","doi-asserted-by":"crossref","unstructured":"McCutcheon K, Bennett J, Marynissen T, Adriaenssens T. Severe focal restenosis 15 months after implantation of a magnesium bioresorbable scaffold. Acta Cardiol 2019 Feb 8 [E-pub ahead of print], doi: https:\/\/doi.org\/10.1080\/00015385.2018.1548109.","DOI":"10.1080\/00015385.2018.1548109"},{"key":"10.1016\/j.carrev.2019.10.012_bb0125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jcin.2017.11.025","article-title":"Optical coherence tomographic image pattern of metallic bioresorbable vascular scaffold restenosis","volume":"11","author":"Roa-Garrido","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.012_bb0130","first-page":"79","article-title":"Early restenosis of resorbable magnesium scaffolds: optical coherence tomography findings","volume":"93","author":"Garcia-Guimaraes","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.012_bb0135","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/j.jcin.2017.07.037","article-title":"Early collapse of a magnesium bioresorbable scaffold","volume":"10","author":"Cubero-Gallego","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.012_bb0140","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1253\/circj.CJ-18-0795","article-title":"Magmaris bioresorbable scaffold - possible dismantling 2 months after implantation on intravascular ultrasound","volume":"83","author":"Mitomo","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2019.10.012_bb0145","first-page":"310","article-title":"Early collapse causing stenosis in a resorbable magnesium scaffold","volume":"92","author":"Marynissen","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.012_bb0150","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4244\/EIJ-D-18-00400","article-title":"Bioabsorbable magnesium scaffold in complex PCI in nickel allergy patient one year follow-up: no disease, no scaffolds","volume":"15","author":"Bayon","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2019.10.012_bb0155","first-page":"768","article-title":"First reported case of magnesium-made bioresorbable scaffold to treat spontaneous left anterior descending coronary artery dissection","volume":"90","author":"Quadri","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.012_bb0160","first-page":"2017","article-title":"Implantation of magnesium-bioresorbable scaffolds in a bifurcation under optical coherence tomography guidance","volume":"38","author":"Jaguszewski","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2019.10.012_bb0165","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.amjcard.2018.12.029","article-title":"Serial 3-dimensional optical coherence tomography assessment of jailed side-branch by second-generation drug-eluting absorbable metal scaffold (from the BIOSOLVE-II trial)","volume":"123","author":"Ozaki","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2019.10.012_bb0170","first-page":"E287","article-title":"Early outcome of magnesium bioresorbable scaffold implantation in acute coronary syndrome-the initial report from the Magmaris-ACS registry","volume":"93","author":"Wlodarczak","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.10.012_bb0175","doi-asserted-by":"crossref","unstructured":"Sabat\u00e9 M, Alfonso F, Cequier A, Roman\u00ed S, Bordes P, Serra A, et al. Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: the MAGSTEMI randomized clinical trial. Circulation 2019 Sep 25 [E-pub ahead of print], doi: https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.043467.","DOI":"10.1161\/CIRCULATIONAHA.119.043467"},{"issue":"40","key":"10.1016\/j.carrev.2019.10.012_bb0180","first-page":"87","article-title":"ESC\/EACTS Guidelines on myocardial revascularization","volume":"2019","author":"Neumann","year":"2018","journal-title":"Eur Heart J"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919306657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919306657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:16:24Z","timestamp":1761560184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838919306657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1553838919306657"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2019.10.012","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second-Generation Drug-Eluting Resorbable Magnesium Scaffold: Review of the Clinical Evidence","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2019.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}